Slate Stone Wealth, LLC Abb Vie Inc. Transaction History

Slate Stone Wealth, LLC

$923 Million
Q2 2024

A detailed history of Slate Stone Wealth, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Slate Stone Wealth, LLC holds 42,611 shares of ABBV stock, worth $8.33 Million. This represents 0.79% of its overall portfolio holdings.

Number of Shares

42,611

Previous 46,488 8.34%

Holding current value

$8.33 Million

Previous $8.47 Million 13.66%

% of portfolio

0.79%

Previous 0.85%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$154.79 - $180.76 $600,120 - $700,806	-3,877 Reduced 8.34%	42,611 $7.31 Million
Q1 2024 Apr 26, 2024	BUY	$159.82 - $182.1 $862,548 - $982,793	5,397 Added 13.13%	46,488 $8.47 Million
Q4 2023 Feb 01, 2024	BUY	$137.6 - $154.97 $7,705 - $8,678	56 Added 0.14%	41,091 $6.37 Million
Q3 2023 Oct 12, 2023	BUY	$133.59 - $154.65 $2.28 Million - $2.64 Million	17,051 Added 71.09%	41,035 $6.12 Million
Q2 2023 Aug 07, 2023	SELL	$132.51 - $164.9 $106,405 - $132,414	-803 Reduced 3.24%	23,984 $3.23 Million
Q1 2023 Aug 08, 2023	BUY	$144.61 - $166.54 $151,117 - $174,034	1,045 Added 4.36%	25,029 $3.99 Million
Q4 2022 Feb 01, 2023	BUY	$138.31 - $165.87 $272,055 - $326,266	1,967 Added 8.62%	24,787 $4.01 Million
Q3 2022 Nov 03, 2022	SELL	$134.21 - $153.93 $30,063 - $34,480	-224 Reduced 0.97%	22,820 $3.06 Million
Q2 2022 Aug 04, 2022	BUY	$137.62 - $174.96 $175,052 - $222,549	1,272 Added 5.84%	23,044 $3.53 Million
Q1 2022 May 04, 2022	SELL	$131.98 - $163.75 $566,326 - $702,651	-4,291 Reduced 16.46%	21,772 $3.53 Million
Q4 2021 Feb 02, 2022	BUY	$107.43 - $135.93 $305,423 - $386,448	2,843 Added 12.24%	26,063 $3.53 Million
Q3 2021 Oct 28, 2021	BUY	$106.4 - $120.78 $416,130 - $472,370	3,911 Added 20.25%	23,220 $2.51 Million
Q2 2021 Aug 02, 2021	SELL	$105.21 - $117.21 $9,574 - $10,666	-91 Reduced 0.47%	19,309 $2.18 Million
Q1 2021 Apr 19, 2021	SELL	$102.3 - $112.62 $77,748 - $85,591	-760 Reduced 3.77%	19,400 $2.1 Million
Q4 2020 Jan 25, 2021	SELL	$80.49 - $108.67 $183,436 - $247,658	-2,279 Reduced 10.16%	20,160 $2.16 Million
Q3 2020 Oct 27, 2020	SELL	$85.91 - $100.83 $477,144 - $560,009	-5,554 Reduced 19.84%	22,439 $1.97 Million
Q2 2020 Jul 29, 2020	BUY	$73.37 - $98.18 $1.14 Million - $1.52 Million	15,491 Added 123.91%	27,993 $2.75 Million
Q1 2020 Apr 28, 2020	SELL	$64.5 - $97.79 $917,706 - $1.39 Million	-14,228 Reduced 53.23%	12,502 $953,000
Q4 2019 Feb 06, 2020	BUY	$72.13 - $90.25 $36,065 - $45,125	500 Added 1.91%	26,730 $2.37 Million
Q3 2019 Nov 05, 2019	SELL	$62.98 - $75.72 $528,717 - $635,669	-8,395 Reduced 24.25%	26,230 $1.99 Million
Q2 2019 Aug 05, 2019	BUY	$65.7 - $83.98 $10,840 - $13,856	165 Added 0.48%	34,625 $2.52 Million
Q1 2019 May 06, 2019	BUY	$77.14 - $90.79 $553,865 - $651,872	7,180 Added 26.32%	34,460 $2.78 Million
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $2.12 Million - $2.62 Million	27,280 New	27,280 $2.52 Million

Others Institutions Holding ABBV

# of Institutions

3,697

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $345B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Slate Stone Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Slate Stone Wealth, LLC with notifications on news.

Account

Slate Stone Wealth, LLC Abb Vie Inc. Transaction History